Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.ImmunityBio, Inc. (NASDAQ: IBRX ) was blindsided this week when the FDA sent a Refusal to File (RTF) letter for the company’s supplemental Biologics License Application (sBLA) for Anktiva in combination with BCG for BCG-unresponsive non-muscle invasiveHe ...